Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Multiple Sclerosis"" wg kryterium: Temat


Tytuł :
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Autorzy :
Petrou P; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Kassis I; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Levin N; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Paul F; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Backner Y; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Benoliel T; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Oertel FC; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Scheel M; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neuroradiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Hallimi M; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Yaghmour N; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Hur TB; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Ginzberg A; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Levy Y; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Abramsky O; Department of Neurology and The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Karussis D; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2020 Dec 01; Vol. 143 (12), pp. 3574-3588.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Mesenchymal Stem Cell Transplantation/*methods
Multiple Sclerosis/*therapy
Adult ; Brain/diagnostic imaging ; Disease Progression ; Double-Blind Method ; Endpoint Determination ; Female ; Follow-Up Studies ; Humans ; Injections, Intravenous ; Injections, Spinal ; Magnetic Resonance Imaging ; Male ; Mesenchymal Stem Cell Transplantation/adverse effects ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/psychology ; Multiple Sclerosis, Chronic Progressive/therapy ; Neuropsychological Tests ; Recurrence ; Tomography, Optical Coherence ; Treatment Outcome ; Walking
Czasopismo naukowe
Tytuł :
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
Autorzy :
Sorensen PS; Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark.
Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark.
Hartung HP; Department of Neurology, University Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Montalban X; Department of Neurology, Hospital General Universitari Vall D'Hebron, Cemcat, Barcelona, Spain.; Division of Neurology, University of Toronto, St. Michael's Hospital, Toronto, Canada.
Comi G; Department of Neurology and Institute of Experimental Neurology, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Tintoré M; Department of Neurology, Hospital General Universitari Vall D'Hebron, Cemcat, Barcelona, Spain.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2020 Sep 01; Vol. 143 (9), pp. 2637-2652.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Demyelinating Diseases/*diagnostic imaging
Demyelinating Diseases/*therapy
Magnetic Resonance Imaging/*trends
Multiple Sclerosis/*diagnostic imaging
Multiple Sclerosis/*therapy
Humans ; Immunosuppressive Agents/therapeutic use ; Multiple Sclerosis, Chronic Progressive/diagnostic imaging ; Multiple Sclerosis, Chronic Progressive/therapy ; Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging ; Multiple Sclerosis, Relapsing-Remitting/therapy
Czasopismo naukowe
Tytuł :
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Autorzy :
Ohlmeier C; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Gothe H; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.; Chair for Health Sciences / Public Health, Medical Faculty 'Carl Gustav Carus', Technical University Dresden, Dresden, Germany.; Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria.
Haas J; Center for Multiple Sclerosis, Jewish Hospital Berlin, Berlin, Germany.
Osowski U; Merck Serono GmbH, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
Weinhold C; Merck Serono GmbH, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
Blauwitz S; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Schmedt N; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
Galetzka W; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
Berkemeier F; Department Health Services Research, IGES Institut GmbH, Berlin, Germany.
Tackenberg B; Center of Neuroimmunology, Philipps-University, Marburg, Germany.
Stangel M; Clinical Neuroimmunology and Neurochemistry, Dept. of Neurology, Hannover Medical School, Hannover, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 May 01; Vol. 15 (5), pp. e0231846. Date of Electronic Publication: 2020 May 01 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Comorbidity ; Female ; Germany ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/epidemiology ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Progress in Multiple Sclerosis Research: An Example of Bedside to Bench.
Autorzy :
Hauser SL; UCSF Weill Institute for Neurosciences and Department of Neurology, University of California, San Francisco.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Sep 01; Vol. 324 (9), pp. 841-842.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Translational Medical Research*
B-Lymphocytes/*immunology
Multiple Sclerosis/*immunology
Multiple Sclerosis/*therapy
Animals ; Antibodies, Monoclonal, Humanized/therapeutic use ; B-Lymphocytes/drug effects ; Central Nervous System/immunology ; Disease Progression ; Encephalomyelitis, Autoimmune, Experimental/pathology ; Humans ; Immunologic Factors/therapeutic use ; Mice ; Multiple Sclerosis, Chronic Progressive/immunology ; Multiple Sclerosis, Chronic Progressive/therapy ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Multiple Sclerosis, Relapsing-Remitting/therapy ; Recurrence ; Research Personnel ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
Autorzy :
Costa Arpín E; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Naveiro Soneira J; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Lema Bouzas M; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
González Quintela A; Intern Medicine Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Prieto González JM; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Pokaż więcej
Źródło :
Acta neurologica Scandinavica [Acta Neurol Scand] 2020 Sep; Vol. 142 (3), pp. 267-274. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis/*epidemiology
Adolescent ; Adult ; Age Factors ; Age of Onset ; Aged ; Aged, 80 and over ; Child ; Databases, Factual ; Delayed Diagnosis ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Multiple Sclerosis/mortality ; Multiple Sclerosis, Chronic Progressive/epidemiology ; Multiple Sclerosis, Chronic Progressive/mortality ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Multiple Sclerosis, Relapsing-Remitting/mortality ; Prevalence ; Sex Factors ; Spain/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion.
Autorzy :
Meuth SG; Abteilung für Neurologie, Universitätsklinikum Münster , Münster, Germany.
Bayas A; Klinik für Neurologie und Klinische Neurophysiologie, Universitätsklinikum Augsburg , Germany.
Kallmann B; Multiple Sklerose Zentrum Bamberg , Germany.
Kleinschnitz C; Klinik für Neurologie, Universitätsklinikum Essen , Germany.
Linker R; Klinik und Poliklinik für Neurologie, Universitätsklinikum Regensburg , Germany.
Rieckmann P; Abteilung für Neurologie, Medical Park Loipl , Germany.
Mäurer M; Klinik für Neurologie, Juliusspital Würzburg Klinikum Würzburg Mitte gGmbH , Germany.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Nov; Vol. 21 (16), pp. 1965-1969. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cladribine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis/*drug therapy
Administration, Oral ; Cladribine/administration & dosage ; Cladribine/adverse effects ; Clinical Trials as Topic ; Drug Administration Schedule ; Drug Monitoring ; Expert Testimony ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Multiple Sclerosis/immunology ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Practice Guidelines as Topic ; Recurrence ; Tablets ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Autorzy :
Breakell T; Institute of Anatomy and Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Tacke S; Institute of Anatomy and Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Schropp V; Institute of Anatomy and Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, 43141 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, 43141 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden.
Urich E; Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center, 4070 Basel, Switzerland.
Kuerten S; Institute of Anatomy and Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Sep 18; Vol. 21 (18). Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Antigens, CD20/*immunology
Antineoplastic Agents, Immunological/*administration & dosage
B-Lymphocytes/*immunology
Encephalomyelitis, Autoimmune, Experimental/*drug therapy
Multiple Sclerosis, Chronic Progressive/*drug therapy
Spinal Cord/*drug effects
Animals ; Antibodies, Monoclonal/administration & dosage ; Antigens, CD20/metabolism ; Axons/drug effects ; Axons/immunology ; Axons/pathology ; B-Lymphocytes/pathology ; Chronic Disease/drug therapy ; Disease Models, Animal ; Encephalomyelitis, Autoimmune, Experimental/immunology ; Encephalomyelitis, Autoimmune, Experimental/pathology ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Microscopy, Electron ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/immunology ; Multiple Sclerosis/pathology ; Multiple Sclerosis, Chronic Progressive/immunology ; Multiple Sclerosis, Chronic Progressive/pathology ; Myelin Basic Protein/immunology ; Myelin Proteolipid Protein/immunology ; Neurofilament Proteins/blood ; Recombinant Fusion Proteins/immunology ; Spinal Cord/immunology ; Spinal Cord/pathology ; Spinal Cord/ultrastructure
Czasopismo naukowe
Tytuł :
Identification of blood-derived candidate gene markers and a new 7-gene diagnostic model for multiple sclerosis.
Autorzy :
Chen X; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Hou H; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Qiao H; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Fan H; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Zhao T; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Dong M; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China. .
Pokaż więcej
Źródło :
Biological research [Biol Res] 2021 Apr 01; Vol. 54 (1), pp. 12. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers*
Gene Expression Profiling*
Leukocytes, Mononuclear*
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/genetics
Computational Biology ; Gene Regulatory Networks ; Humans ; Oligonucleotide Array Sequence Analysis
Czasopismo naukowe
Tytuł :
Impact of aerobic exercise on clinical and magnetic resonance imaging biomarkers in persons with multiple sclerosis: An exploratory randomized controlled trial.
Autorzy :
Savšek L; Department of Neurology, General Hospital Celje, Celje, Slovenia. E-mail: .
Stergar T
Strojnik V
Ihan A
Koren A
Špiclin Ž
Šega Jazbec S
Pokaż więcej
Źródło :
Journal of rehabilitation medicine [J Rehabil Med] 2021 Apr 01; Vol. 53 (4), pp. jrm00178. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Exercise/*physiology
Magnetic Resonance Imaging/*methods
Multiple Sclerosis/*diagnostic imaging
Multiple Sclerosis/*therapy
Adult ; Female ; Humans ; Longitudinal Studies ; Male ; Multiple Sclerosis/pathology
Czasopismo naukowe
Tytuł :
Viral mouse models used to study multiple sclerosis: past and present.
Autorzy :
Libbey JE; Department of Pathology, University of Utah School of Medicine, 15 North Medical Drive East, 2600 EEJMRB, Salt Lake City, UT, 84112, USA.
Fujinami RS; Department of Pathology, University of Utah School of Medicine, 15 North Medical Drive East, 2600 EEJMRB, Salt Lake City, UT, 84112, USA. .
Pokaż więcej
Źródło :
Archives of virology [Arch Virol] 2021 Apr; Vol. 166 (4), pp. 1015-1033. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Models, Animal*
Multiple Sclerosis/*pathology
Multiple Sclerosis/*virology
RNA Virus Infections/*pathology
RNA Virus Infections/*virology
Animals ; Central Nervous System/pathology ; Central Nervous System/physiology ; Central Nervous System/virology ; Humans ; Mice ; Multiple Sclerosis/immunology ; Multiple Sclerosis/physiopathology ; Murine hepatitis virus/pathogenicity ; Murine hepatitis virus/physiology ; RNA Virus Infections/immunology ; RNA Virus Infections/physiopathology ; Semliki forest virus/pathogenicity ; Semliki forest virus/physiology ; Theilovirus/pathogenicity ; Theilovirus/physiology
Czasopismo naukowe
Tytuł :
[Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].
Autorzy :
Domurath B; Neuro-Urologisches Zentrum, Kliniken Beelitz GmbH, Paracelsusring 6A, 14547, Beelitz Heilstätten, Deutschland. .
Flachenecker P; Neurologisches Rehabilitationszentrum Quellenhof, Bad Wildbad, Deutschland.
Henze T; Praxis für Neurologie Dr. Blersch, Regensburg, Deutschland.
Feneberg W; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gemeinnützige GmbH, Berg, Deutschland.
Brandt A; Neurologisches Zentrum, Segeberger Kliniken, Bad Segeberg, Deutschland.
Kurze I; Querschnittgelähmten-Zentrum, Klinik für Paraplegiologie und Neuro-Urologie, Zentralklinik Bad Berka GmbH, Bad Berka, Deutschland.
Kirschner-Hermanns R; Sektion Neurourologie, Klinik für Urologie und Kinderurologie, Universitätsklinikum Bonn und Neuro-Urologie, Neurologisches Rehabilitationszentrum der 'Godeshöhe' e. V., Bonn, Deutschland.
Kaufmann A; Zentrum für Kontinenz und Neuro-Urologie, Kliniken Maria Hilf GmbH, Mönchengladbach, Deutschland.
Bremer J; Querschnittgelähmtenzentrum, BDH Klinik Greifswald gGmbH, Greifswald, Deutschland.
Vonthien M; Coloplast GmbH, Kühnstr. 75, 22045, Hamburg, Deutschland.
Ratering K; Coloplast GmbH, Kühnstr. 75, 22045, Hamburg, Deutschland.
Schäfer C; Rehaklinik für Neurologie und Orthopädie, Johanniter-Klinik am Romberg, Dortmund, Deutschland.
Vance WN; Neuro-Urologisches Zentrum, Kliniken Beelitz GmbH, Paracelsusring 6A, 14547, Beelitz Heilstätten, Deutschland.
Schmidt P; Statistik, Große Seestraße, 813086, Berlin, Deutschland.
Pokaż więcej
Transliterated Title :
Aktuelles zu neurogenen Dysfunktionen des unteren Harntraktes bei Multipler Sklerose.
Źródło :
Der Nervenarzt [Nervenarzt] 2021 Apr; Vol. 92 (4), pp. 349-358. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Multiple Sclerosis*/complications
Multiple Sclerosis*/diagnosis
Urologic Diseases*
Humans ; Prospective Studies ; Urodynamics
Czasopismo naukowe
Tytuł :
COVID-19 in ocrelizumab-treated people with multiple sclerosis.
Autorzy :
Hughes R; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Whitley L; TranScrip Partners LLP, Wokingham, UK.
Fitovski K; F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: .
Schneble HM; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Muros E; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Sauter A; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Craveiro L; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Dillon P; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bonati U; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Jessop N; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pedotti R; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Koendgen H; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Apr; Vol. 49, pp. 102725. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Antibodies, Monoclonal, Humanized/*therapeutic use
COVID-19/*complications
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Electronic Health Records ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Another 'BEE'? - Brain-Eye-Ear (BEE) Disease Secondary to HbSC Disease Masquerading as Multiple Sclerosis.
Autorzy :
Wallach AI; Former Affiliation/Place Clinical Care was provided: NYU MS Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, USA; Current Affiliation/ Place Manuscript was written: Alfiero and Lucia Palestroni MS Comprehensive Care Center, Holy Name Medical Center, New Jersey, USA. Electronic address: .
Borja MJ; Division of Neuroradiology, Department of Radiology, NYU Langone Health, New York, USA.
Chen D; Division of Neuroradiology, Department of Radiology, NYU Langone Health, New York, USA.
Eisenberg R; Allergy & Immunology, Department of Pediatrics, Children's Hospital at Montefiore, New York, USA.
Modi YS; Department of Ophthalmology, NYU Langone Health, New York, USA.
Zhang C; Division of Vascular Neurology, Department of Neurology, NYU Langone Health, New York, USA.
Shepherd TM; Division of Neuroradiology, Department of Radiology, NYU Langone Health, New York, USA.
Nath A; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke and National Institutes of Health, New York, USA.
Smith B; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke and National Institutes of Health, New York, USA.
Scher JU; Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, USA.
Cho C; Division of Otoneurology, Departments of Neurology and Otolaryngology, NYU Langone Health, New York, USA.
Kister I; NYU MS Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, USA.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Apr; Vol. 30 (4), pp. 105618. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :
Case Reports
MeSH Terms :
Whole Exome Sequencing*
Hearing Loss, Unilateral/*etiology
Hemoglobin SC Disease/*diagnosis
Hemoglobins, Abnormal/*genetics
Leukoencephalopathies/*etiology
Multiple Sclerosis/*diagnosis
Vision Disorders/*etiology
Diagnostic Errors ; Genetic Predisposition to Disease ; Hearing Loss, Unilateral/diagnosis ; Hearing Loss, Unilateral/physiopathology ; Hemoglobin SC Disease/complications ; Hemoglobin SC Disease/genetics ; Humans ; Leukoencephalopathies/diagnostic imaging ; Leukoencephalopathies/physiopathology ; Magnetic Resonance Imaging ; Male ; Multiple Sclerosis/complications ; Multiple Sclerosis/drug therapy ; Phenotype ; Predictive Value of Tests ; Vision Disorders/diagnosis ; Vision Disorders/physiopathology ; Young Adult
Raport
Tytuł :
New insights into the socio-economic aspects of multiple sclerosis in a cohort of Polish patients.
Autorzy :
Rzepiński Ł; Department of Neurology, 10th Military Research Hospital and Polyclinic, Bydgoszcz, Poland.
Zawadka-Kunikowska M; Department of Hygiene, Epidemiology and Ergonomy, Nicolaus Copernicus University, Torun, Poland.
Kucharczuk J; Department of Ophthalmology, 10th Military Research Hospital and Polyclinic, Bydgoszcz, Poland.
Newton J; Institute of Cellular Medicine, Newcastle University, United Kingdom.
Zalewski P; Department of Hygiene, Epidemiology and Ergonomy, Nicolaus Copernicus University, Torun, Poland.
Pokaż więcej
Źródło :
Annals of agricultural and environmental medicine : AAEM [Ann Agric Environ Med] 2021 Mar 18; Vol. 28 (1), pp. 99-106. Date of Electronic Publication: 2020 Feb 24.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Employment/*economics
Multiple Sclerosis/*economics
Adult ; Disclosure ; Employment/psychology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/psychology ; Poland ; Retrospective Studies ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis.
Autorzy :
Martire S; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.
Montarolo F; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.; Department of Molecular Biotechnologies and Health Sciences, University of Turin, 10124 Turin, Italy.
Spadaro M; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.
Perga S; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.; Department of Neuroscience Rita Levi-Montalcini, University of Turin, 10124 Turin, Italy.
Sforza ML; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.
Marozio L; Department of Surgical Sciences, Obstetrics and Gynaecology, University of Turin, 10124 Turin, Italy.
Frezet F; Department of Surgical Sciences, Obstetrics and Gynaecology, University of Turin, 10124 Turin, Italy.
Bruno S; Department of Medical Sciences and Molecular Biotechnology Center, University of Turin, 10124 Turin, Italy.
Chiabotto G; Department of Medical Sciences and Molecular Biotechnology Center, University of Turin, 10124 Turin, Italy.
Deregibus MC; 2i3T Business Incubator and Technology Transfer, University of Turin, 10124 Turin, Italy.
Camussi G; Department of Medical Sciences and Molecular Biotechnology Center, University of Turin, 10124 Turin, Italy.
Botta G; Department of Pathology, Città della Salute e della Scienza di Torino, 10124 Turin, Italy.
Benedetto C; Department of Surgical Sciences, Obstetrics and Gynaecology, University of Turin, 10124 Turin, Italy.
Bertolotto A; Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043 Turin, Italy.; Neurology-CRESM (Regional Reference Center for Multiple Sclerosis), AOU San Luigi Gonzaga, Orbassano, 10043 Turin, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 12; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Extracellular Vesicles/*genetics
Immunity/*genetics
Multiple Sclerosis/*genetics
Proteome/*genetics
Cell Communication/genetics ; Coculture Techniques ; Cytokines/genetics ; Decidua/immunology ; Decidua/metabolism ; Extracellular Vesicles/immunology ; Female ; Humans ; Immunomodulation/genetics ; Multiple Sclerosis/immunology ; Multiple Sclerosis/pathology ; Placenta/immunology ; Placenta/metabolism ; Pregnancy ; T-Lymphocytes, Regulatory/immunology ; Trophoblasts/immunology ; Trophoblasts/metabolism
Czasopismo naukowe
Tytuł :
Hypoxia in multiple sclerosis; is it the chicken or the egg?
Autorzy :
Halder SK; San Diego Biomedical Research Institute, 10865 Road to the Cure, Suite 100, San Diego, CA 92121, USA.
Milner R; San Diego Biomedical Research Institute, 10865 Road to the Cure, Suite 100, San Diego, CA 92121, USA.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2021 Mar 03; Vol. 144 (2), pp. 402-410.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Hypoxia/*physiopathology
Multiple Sclerosis/*physiopathology
Animals ; Blood-Brain Barrier/pathology ; Blood-Brain Barrier/physiopathology ; Humans ; Hypoxia/complications ; Hypoxia/pathology ; Mitochondria/physiology ; Multiple Sclerosis/complications ; Multiple Sclerosis/pathology
Czasopismo naukowe
Tytuł :
[The pharmacological economic analysis of application of magnetic resonance contrast mediums containing gadolinium in case of multiple sclerosis].
Autorzy :
Shegay MM; N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.
Shimanovsky DN; I. M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University), 119991, Moscow, Russia, .
Pokaż więcej
Źródło :
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny [Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med] 2021 Mar; Vol. 29 (2), pp. 343-346.
Typ publikacji :
Journal Article
MeSH Terms :
Gadolinium*
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/drug therapy
Contrast Media ; Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy
Czasopismo naukowe
Tytuł :
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? No.
Autorzy :
Labauge P; CRC SEP, Department of Neurology, Montpellier University Hospital, CHU de Montpellier, 34295 Montpellier cedex 5, France. Electronic address: .
Pokaż więcej
Źródło :
Revue neurologique [Rev Neurol (Paris)] 2020 Jun; Vol. 176 (6), pp. 494-496. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Historical Article; Journal Article
MeSH Terms :
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis/*drug therapy
Multiple Sclerosis, Relapsing-Remitting/*prevention & control
Adult ; Disease Progression ; Female ; History, 20th Century ; History, 21st Century ; Humans ; Immunosuppressive Agents/classification ; Longitudinal Studies ; Male ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis/pathology ; Multiple Sclerosis, Chronic Progressive/epidemiology ; Multiple Sclerosis, Chronic Progressive/prevention & control ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Pharmaceutical Preparations/classification ; Recurrence
Czasopismo naukowe
Tytuł :
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
Autorzy :
Souza KM; Programa de Pós-Graduação em Saúde Baseada em Evidências, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
Diniz IM; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Lemos LLP; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Saúde Pública, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Junior NGR; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Zuppo IF; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Teodoro JA; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Acurcio FA; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Saúde Pública, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Atallah ÁN; Programa de Pós-Graduação em Saúde Baseada em Evidências, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.; Cochrane Brazil, Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde, São Paulo, São Paulo, Brazil.
Júnior AAG; SUS Collaborating Centre for Technology Assessment & Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 02; Vol. 15 (9), pp. e0238476. Date of Electronic Publication: 2020 Sep 02 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Treatment Outcome*
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Adjuvants, Immunologic/therapeutic use ; Adult ; Brazil/epidemiology ; Cohort Studies ; Cost-Benefit Analysis ; Female ; Glatiramer Acetate/therapeutic use ; Humans ; Interferon-beta/therapeutic use ; Kaplan-Meier Estimate ; Male ; Multiple Sclerosis/drug therapy ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies